FDA Inspection
RiconPharma LLCRiconPharma LLC – FDA Inspection, Sep 20, 2024
Record Details
This FDA Inspection record concerns RiconPharma LLC, with an inspection on September 20, 2024, issued by the New Jersey District Office, covering human drugs.
View Company Profile
ID · b2fe9bfd-fc81-47dd-900c-5abc6ad3efa5
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1249674
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
- Outcome
- Form 483 issued
FDA Citations
1- 21 CFR 211.22(d)Procedures not in writing, fully followed
Full citation text and observation details available on the Dashboard.
Other FDA inspections of RiconPharma LLC
7| Date | Classification | Office | Project area |
|---|---|---|---|
| September 24, 2026 | Not classified | New Jersey District Office | |
| November 9, 2021 | NAI | Center for Drug Evaluation and Research | Bioresearch Monitoring |
| September 13, 2019 | NAI | Center for Drug Evaluation and Research | Bioresearch Monitoring |
| January 9, 2017 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| January 21, 2015 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for RiconPharma LLC
- FDA Inspection 1344452 - 2026-09-24
- FDA Inspection 1157388 - 2021-11-09
- FDA Inspection 1105217 - 2019-09-13
- FDA Inspection 998568 - 2017-01-09
- FDA Inspection 910604 - 2015-01-21
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.